Medicine recalls
|
| |
| Canada: Two lots of the epilepsy drug Primidone recalled because of high levels of lead, which may pose serious health risks |
| |
Health Canada is advising Canadians that AA Pharma Inc. is voluntarily recalling two lots of Primidone tablets because they contain high levels of lead. The company has indicated that only the lots identified below are affected by this issue. The affected products are:
- Primidone 125mg tablet (lot number: MT4040; expiry: 05/2021)
- Primidone 250mg tablet (lot number: MM3274; expiry: 10/2020)
Primidone is a prescription anti-epileptic drug used to control seizures. Lead is a heavy metal and can pose serious health risks when too much is ingested, particularly by children, and pregnant and breastfeeding women. Lead consumed in excessive amounts poses serious health risks because it may accumulate in vital organs of the body. Toxic effects include miscarriage and other reproductive effects, kidney and brain damage, abdominal pain, anemia, loss of appetite, constipation, fatigue, sleeplessness, irritability, headache, changes in blood pressure, weakness, concentration problems, weight loss, and dizziness. Children, and pregnant and breastfeeding women are the most susceptible to the toxic effects.
Please refer to the following website in Health Canada for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../66430a-eng.php
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Monday, Apr 9, 2018
Issued at HKT 15:00
|
| |
